Thanks to the latest Prescription Drug User Fee Act (PDUFA VI), the US Food and Drug Administration (FDA) will soon launch a pilot program on complex clinical trial designs, according to the public ...
The US Food and Drug Administration will hold a meeting on 20 March to discuss the use of complex innovative designs (CID) in clinical trials of drugs and biological products to inform regulatory ...
BOSTON--(BUSINESS WIRE)--DeepCure, a leader in discovering novel therapeutics powered by AI and automation, announced today that its Inspired Chemistry™ platform had achieved a breakthrough in ...
Bingchuan Wei identifies the toughest unresolved analytical challenges in ADC development and highlights the emerging ...
Quantitative mass spectrometry-based proteomic experiments are designed to answer increasingly complex questions. For example, we may want to characterize changes in protein abundance in biological ...
Today’s additive manufacturing part designs are becoming more complex and pushing the limits of manufacturing, explained Egwin Bovyn, Magics product line manager for Materialise, at Rapid+TCT 2024.